Departments
Hematology
Specialty
Internal Medicine
Languages
English, Thai
2021
Doctor of Medicine, แพทยศาสตรบัณฑิต , Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand
- 2026 Clinical Fellowship in Bone Marrow Transplantation, King Chulalongkorn Memorial Hospital (KCMH), Thailand.
- 2025 Fellowship Training in Hematology, Phramongkutklao Hospital,
- 2023 Residency Training Program in Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
- Acute leukemia (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia)
- Chronic leukemia (Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia)
- Lymphomas (Hodgkin lymphoma and Non?Hodgkin lymphoma)
- Multiple myeloma and plasma cell disorders
- Myelodysplastic syndromes (MDS)
- Myeloproliferative neoplasms (MPN)
- Other hematologic cancers and bone marrow failure syndromes
- Indications for CAR?T cell therapy
- Diseases requiring autologous stem cell transplantation
- Diseases requiring allogeneic stem cell transplantation
- Relapsed or refractory hematologic malignancies
- Graft?versus?host disease (GVHD)
- Transplant?related infections and complications
- Chemotherapy?related complications
- Post?transplant immune and hematologic disorders
- CAR-T therapy
- Bone Marrow Transplantation
- Bone marrow aspiration and biopsy
- Peripheral blood smear interpretation
- Diagnostic evaluation and management of hematologic malignancies
- Administration and monitoring of chemotherapy for hematologic diseases
- Transfusion medicine and blood component therapy
- Management of anemia, thrombocytopenia, and coagulation disorders
- Therapeutic phlebotomy
- Supportive care for patients with hematologic disorders
- Pre?transplant evaluation and donor assessment
- Autologous hematopoietic stem cell transplantation
- Allogeneic hematopoietic stem cell transplantation
- Stem cell infusion and post?transplant care
- Management of transplant?related complications
- Diagnosis and management of graft?versus?host disease (GVHD)
- Long?term follow?up of transplant recipients
- Best Poster Presentation, Prognostic outcomes of diffuse large B-cell lymphoma patients with MYC and BCL2 co-expression, Thai society of hematology (TSH) Annual meeting, Bangkok; 2024.
- Oral presentation, Optimization of pre-apheresis blood CD34 value for guiding plerixafor administration as rescue therapy to succeed in peripheral blood stem cell mobilization for lymphoma patients with poor mobilizers, 40th world congress of international society of hematology, Bangkok; 2025
- Thai Society of Hematology (TSH)
- Medical Council of Thailand
- CAR-T therapy in multiple myeloma and diffuse large B-cell lymphoma (DLBCL) : implementation, vein-to-vein time, toxicity pathways, and real-world outcomes.
- Allogeneic HSCT: optimization of transplant outcomes, graft-versus-host disease (GVHD) prevention, and long-term survivorship care.
| For appointments & inquiries please contact |
|---|
| Doctor Appointment Call : 02-734-0000 |
Publications
Other Information
0 Patient Satisfaction Review
There are no reviews yet. Be the first one to write one.
